Kaigene, Inc., a U.S. biotechnology company focused on developing next-generation antibody therapies for autoimmune diseases, has announced an exclusive licensing partnership with Taisho Pharmaceutical Co., Ltd., one of Japan’s leading …
Harbour BioMed, a global biopharmaceutical company focused on advancing innovative antibody-based therapies in immunology and immune-oncology, has announced the online publication of results from the first-in-human Phase I clinical trial …
We’re committed to advancing innovation in virology, oncology, and immunology, with a strong emphasis on supporting groundbreaking science that transforms cancer treatment. In the newest episode of The Centrifuge Sessions, …
